An Overview of Reviews on Telemedicine and Telehealth in Dementia Care: Mixed Methods Synthesis.

Israel Júnior Borges do Nascimento, Hebatullah Mohamed Abdulazeem, Ishanka Weerasekara, Amin Sharifan, Victor Grandi Bianco, Indunil Kularathne, Ciara Cunningham, Brijesh Sathian, Genevieve Deeken, Lasse Østengaard, Rachel Frederique-Djurdjevic, Joost van Hoof, Ledia Lazeri, Cassie Redlich, Hannah R Marston, Nathalia Sernizon Guimarães, Jerome de Barros, Ryan Alistar Dos Santos, Natasha Azzopardi-Muscat, Yongjie Yon, David Novillo-Ortiz

Journal: JMIR mental health 2025;12():e75266

PMID: 41194522

Abstract

BACKGROUND

Population aging has intensified the global burden of dementia, creating significant challenges for patients, caregivers, and health care systems. While traditional in-person dementia care faces barriers, digital health technologies offer promising solutions to enhance accessibility, efficiency, and patient-centered care. However, evidence on applicability, safety, and effectiveness in dementia care remains fragmented, underscoring systematic evaluation.

OBJECTIVE

This study aims to assess the effectiveness, applicability, safety, and cost-efficiency of telemedicine technologies in dementia care, providing a comprehensive summary of evidence spanning clinical, psychological, socioeconomic, and operational impacts for persons living with dementia and their caregivers and assess alignment with the World Health Organization (WHO) Age-friendly Cities and Communities' Framework and Dementia Inclusive Society Framework.

METHODS

An overview of systematic and scoping reviews was conducted following a search in 5 databases (MEDLINE, Embase, Scopus, Epistemonikos, and Cochrane Database of Systematic Reviews), with a gray literature search on February 20, 2024. Eligible studies reported predefined outcomes related to telemedicine interventions for integrated dementia care, including effects on mental health, quality of life, physical activity, hospitalization, financial costs, safety, social isolation, and motor function. Screening and data extraction were performed by 10 reviewers. The findings were synthesized using the Thematic Analysis in Meta-Evidence (TAME) methodology, combining thematic and lexical analyses with single-proportion meta-analysis for comprehensive qualitative-quantitative synthesis. The methodological quality was assessed using the AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews), with GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative Research) for outcomes' confidence in evidence.

RESULTS

Ninety-one reviews provided evidence on the impact of telemedicine in dementia care. The most frequently reported outcomes were the effects of remote interventions on psychiatric and psychological well-being, particularly depression and anxiety (relative frequency of occurrence [RFO]=65%, 95% CI 54-75, moderate certainty of evidence). Fifty-seven studies highlighted the positive impact of telemedicine and telehealth on satisfaction and quality of life for persons living with dementia, caregivers, and health care providers (RFO=63%, 95% CI 52-73, moderate certainty of evidence). Remote technology-related interventions for reducing falls and managing behavioral symptoms were also frequently reported (RFO=33% 95% CI 23-44], moderate certainty of evidence). These interventions showed effectiveness in alleviating social isolation and loneliness (RFO=31%, 95% CI 22-41, moderate certainty of evidence). The methodological quality of the included reviews varied significantly, with the majority rated as low or critically low quality.

CONCLUSIONS

Telemedicine and telehealth have been demonstrated to be effective and valuable tools in dementia care, offering significant benefits across psychological well-being, quality of life, and social impacts for persons living with dementia and their caregivers. This supports the adoption and implementation of telemedicine in dementia care, aligning with the strategies outlined in the United Nations Decade of Healthy Ageing (2021-2030).

© Israel Júnior Borges do Nascimento, Hebatullah Mohamed Abdulazeem, Ishanka Weerasekara, Amin Sharifan, Victor Grandi Bianco, Indunil Kularathne, Ciara Cunningham, Brijesh Sathian, Genevieve Deeken, Lasse Østengaard, Rachel Frederique-Djurdjevic, Joost van Hoof, Ledia Lazeri, Cassie Redlich, Hannah R Marston, Nathalia Sernizon Guimarães, Jerome de Barros, Ryan Alistar dos Santos, Natasha Azzopardi-Muscat, Yongjie Yon, David Novillo-Ortiz. Originally published in JMIR Mental Health (https://mental.jmir.org).

Address: Division of Country Health Policies and Systems, World Health Organization Regional Office for Europe, Marmorvej 51, Copenhagen, 2100, Denmark, 45 45337198.; Center for Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité and Université Sorbonne Paris Nord, INRAE, Inserm, Hôpital Hôtel-Dieu, 1, Paris, France.; Department of Internal Medicine, School of Medicine and Hospital Universitário Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.; Division of Country Health Policies and Systems, World Health Organization Regional Office for Europe, Marmorvej 51, Copenhagen, 2100, Denmark, 45 45337198.; Chair of Epidemiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.; Institute of Health and Wellbeing, Federation University, Churchill, Australia.; School of Health Sciences, University of Newcastle Australia, Callaghan, Australia.; Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria.; Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas (NEPAD), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.; Sports Medicine Unit, National Hospital of Kandy, Kandy, Sri Lanka.; Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka.; Center for Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité and Université Sorbonne Paris Nord, INRAE, Inserm, Hôpital Hôtel-Dieu, 1, Paris, France.; Geriatrics and Long-Term Care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.; Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Division of Country Health Policies and Systems, World Health Organization Regional Office for Europe, Marmorvej 51, Copenhagen, 2100, Denmark, 45 45337198.; Faculty of Spatial Management and Landscape Architecture, Department of Systems Research, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.; Research Group of Urban Ageing, Faculty of Social Work and Education, The Hague University of Applied Sciences, Den Haag, The Netherlands.; Research Group of Urban Ageing, Faculty of Social Work and Education, The Hague University of Applied Sciences, Den Haag, The Netherlands.; School of Health, Wellbeing and Social Care, The Open University, Milton Keynes, United Kingdom.; Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Minas Gerais, Brazil.; Directorate-General for Health and Food Safety, European Commission, Brussels, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.